IL-23 and IL-17 in tuberculosis.

[1]  Francesco Bistoni,et al.  IL‐23 and the Th17 pathway promote inflammation and impair antifungal immune resistance , 2007, European journal of immunology.

[2]  M. Egger,et al.  Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis. , 2007, The Lancet. Infectious diseases.

[3]  C. Tato,et al.  Distinct regulation of interleukin-17 in human T helper lymphocytes. , 2007, Arthritis and rheumatism.

[4]  Kathleen M. Smith,et al.  Development, cytokine profile and function of human interleukin 17–producing helper T cells , 2007, Nature Immunology.

[5]  Brigitta Stockinger,et al.  Differentiation and function of Th17 T cells. , 2007, Current opinion in immunology.

[6]  Chi‐Huey Wong,et al.  Brief Definitive Report Identifi Cation of an Il-17–producing Nk1.1 Neg Inkt Cell Population Involved in Airway Neutrophilia , 2022 .

[7]  R. Locksley,et al.  IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge , 2007, Nature Immunology.

[8]  S. Nakae,et al.  IL-17-Mediated Regulation of Innate and Acquired Immune Response against Pulmonary Mycobacterium bovis Bacille Calmette-Guérin Infection1 , 2007, The Journal of Immunology.

[9]  W. Britton,et al.  Interleukin-23 Restores Immunity to Mycobacterium tuberculosis Infection in IL-12p40-Deficient Mice and Is Not Required for the Development of IL-17-Secreting T Cell Responses1 , 2006, The Journal of Immunology.

[10]  Judy H. Cho,et al.  A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene , 2006, Science.

[11]  J. Casanova,et al.  Inborn errors of IL-12/23- and IFN-γ-mediated immunity: molecular, cellular, and clinical features , 2006 .

[12]  J. Flynn,et al.  IL-17 Production Is Dominated by γδ T Cells rather than CD4 T Cells during Mycobacterium tuberculosis Infection1 , 2006, The Journal of Immunology.

[13]  L. Hennighausen,et al.  Interleukin 27 negatively regulates the development of interleukin 17–producing T helper cells during chronic inflammation of the central nervous system , 2006, Nature Immunology.

[14]  Zihua Hu,et al.  Identification of Common Transcriptional Regulatory Elements in Interleukin-17 Target Genes* , 2006, Journal of Biological Chemistry.

[15]  T. Mcclanahan,et al.  Neutralization or Absence of the Interleukin-23 Pathway Does Not Compromise Immunity to Mycobacterial Infection , 2006, Infection and Immunity.

[16]  D. Danilenko,et al.  Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17–producing T cells , 2006, Nature Immunology.

[17]  J. Pedrosa,et al.  Cutting Edge: IFN-γ Regulates the Induction and Expansion of IL-17-Producing CD4 T Cells during Mycobacterial Infection1 , 2006, The Journal of Immunology.

[18]  R. D. Hatton,et al.  Transforming growth factor-β induces development of the TH17 lineage , 2006, Nature.

[19]  T. Ottenhoff,et al.  Divergent effects of IL‐12 and IL‐23 on the production of IL‐17 by human T cells , 2006, European journal of immunology.

[20]  R. J. Hocking,et al.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. , 2006, Immunity.

[21]  W. Britton,et al.  Plasmid Interleukin-23 (IL-23), but Not Plasmid IL-27, Enhances the Protective Efficacy of a DNA Vaccine against Mycobacterium tuberculosis Infection , 2006, Infection and Immunity.

[22]  C. Mason,et al.  Pulmonary Interleukin-23 Gene Delivery Increases Local T-Cell Immunity and Controls Growth of Mycobacterium tuberculosis in the Lungs , 2005, Infection and Immunity.

[23]  G. Nau.  Faculty Opinions recommendation of IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available. , 2005 .

[24]  S. Khader,et al.  IL-23 Compensates for the Absence of IL-12p70 and Is Essential for the IL-17 Response during Tuberculosis but Is Dispensable for Protection and Antigen-Specific IFN-γ Responses if IL-12p70 Is Available1 , 2005, The Journal of Immunology.

[25]  Yu-Jin Jung,et al.  Properties and protective value of the secondary versus primary T helper type 1 response to airborne Mycobacterium tuberculosis infection in mice , 2005, The Journal of experimental medicine.

[26]  J. Lötvall,et al.  Interleukin-17 as a recruitment and survival factor for airway macrophages in allergic airway inflammation. , 2005, American journal of respiratory cell and molecular biology.

[27]  T. Mak,et al.  The IL-27 Receptor Chain WSX-1 Differentially Regulates Antibacterial Immunity and Survival during Experimental Tuberculosis 1 , 2005, The Journal of Immunology.

[28]  K. Ley,et al.  Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. , 2005, Immunity.

[29]  S. Khader,et al.  IL-27 Signaling Compromises Control of Bacterial Growth in Mycobacteria-Infected Mice1 , 2004, The Journal of Immunology.

[30]  A. Lindén,et al.  Interleukin-17 family members and inflammation. , 2004, Immunity.

[31]  J. Casanova,et al.  A novel form of complete IL-12/IL-23 receptor beta1 deficiency with cell surface-expressed nonfunctional receptors. , 2004, Blood.

[32]  Y. Lau,et al.  Associations between IL12B polymorphisms and tuberculosis in the Hong Kong Chinese population. , 2004, The Journal of infectious diseases.

[33]  S. Ehlers,et al.  A Limited Antigen-Specific Cellular Response Is Sufficient for the Early Control of Mycobacterium tuberculosis in the Lung but Is Insufficient for Long-Term Survival , 2004, Infection and Immunity.

[34]  T. Ottenhoff,et al.  IL‐12 receptor deficiency revisited: IL‐23‐mediated signaling is also impaired in human genetic IL‐12 receptor β1 deficiency , 2003, European journal of immunology.

[35]  J. Lötvall,et al.  Endogenous IL-17 as a Mediator of Neutrophil Recruitment Caused by Endotoxin Exposure in Mouse Airways1 , 2003, The Journal of Immunology.

[36]  M. Harada,et al.  Influence of interleukin-12 receptor β1 polymorphisms on tuberculosis , 2003, Human Genetics.

[37]  Alan D. Roberts,et al.  Persistence and Turnover of Antigen-Specific CD4 T Cells During Chronic Tuberculosis Infection in the Mouse 1 , 2003, The Journal of Immunology.

[38]  O. Sanal,et al.  Severe Mycobacterium bovis BCG infections in a large series of novel IL–12 receptor β1 deficient patients and evidence for the existence of partial IL–12 receptor β1 deficiency , 2003, European journal of immunology.

[39]  C. Dascher,et al.  Dissemination of Mycobacterium tuberculosis Is Influenced by Host Factors and Precedes the Initiation of T-Cell Immunity , 2002, Infection and Immunity.

[40]  R. Döffinger,et al.  Inherited disorders of IL-12- and IFNgamma-mediated immunity: a molecular genetics update. , 2002, Molecular immunology.

[41]  I. Orme,et al.  Mice Lacking Bioactive IL-12 Can Generate Protective, Antigen-Specific Cellular Responses to Mycobacterial Infection Only if the IL-12 p40 Subunit Is Present1 , 2002, The Journal of Immunology.

[42]  John Chan,et al.  Tuberculosis: Latency and Reactivation , 2001, Infection and Immunity.

[43]  M. Matsuoka,et al.  Missense mutation of the interleukin-12 receptor beta1 chain-encoding gene is associated with impaired immunity against Mycobacterium avium complex infection. , 2001, Blood.

[44]  R. North,et al.  The Relative Importance of T Cell Subsets in Immunity and Immunopathology of Airborne Mycobacterium tuberculosis Infection in Mice , 2001, The Journal of experimental medicine.

[45]  S. Ehlers,et al.  Expression of the Nitric Oxide Synthase 2 Gene Is Not Essential for Early Control of Mycobacterium tuberculosis in the Murine Lung , 2000, Infection and Immunity.

[46]  I. Orme,et al.  An anti-inflammatory role for gamma delta T lymphocytes in acquired immunity to Mycobacterium tuberculosis. , 1997, Journal of immunology.

[47]  C. Lowenstein,et al.  Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. , 1995, Immunity.

[48]  C S Berkey,et al.  Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. , 1994, JAMA.

[49]  Lianyu Shan,et al.  IL-17 attenuates the anti-apoptotic effects of GM-CSF in human neutrophils. , 2008, Molecular immunology.

[50]  J. Flynn,et al.  IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. , 2006, Journal of immunology.

[51]  J. Casanova,et al.  Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. , 2006, Seminars in immunology.

[52]  I. Orme,et al.  Expression of memory immunity in the lung following re-exposure to Mycobacterium tuberculosis. , 1997, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[53]  I. Orme,et al.  Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis. , 1997, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[54]  G. Colditz,et al.  Relationship between bacille Calmette-Guérin (BCG) strains and the efficacy of BCG vaccine in the prevention of tuberculosis. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[55]  I. Orme,et al.  Materials and Methods Briefdefinitive Report Disseminated Tuberculosis in Interferon 7 Gene-disrupted Mice , 2022 .